MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Bionik Laboratories Arms Tampa General Hospital with InMotion Robotic Device

Article-Bionik Laboratories Arms Tampa General Hospital with InMotion Robotic Device

Image courtesy of Thomas Lukassek / Alamy Stock Photo IMG_2022-6-24-140021.jpg
The Tampa General facility has purchased and installed the InMotion Arm/Hand Interactive Therapy System for its Rehabilitation Hospital to aid those recovering from stroke, brain injury, and neurological conditions.

Bionik Laboratories Corp., a robotics company that provides rehabilitation and assistive technology solutions to stroke survivors and others with neurological and mobility challenges from hospital to home, announced that Tampa General Hospital (TGH), a part of the Kindred Healthcare network, has purchased and recently installed the company’s InMotion ARM/HAND Interactive Therapy System for use at its Rehabilitation Hospital. The purchase is part of the hospital’s mission to offer customized, intense rehabilitation tailored to the individual needs of those recovering from stroke, brain injury, neurological conditions, and more.

InMotion robotic therapy guides the patient through specific tasks with the goal is of improving motor control of the arm and hand by increasing strength, range of motion, and coordination. This is accomplished by training shoulder protraction/retraction, flexion/extension, abduction/adduction, internal/external rotation, elbow flexion/extension, and hand grasp/release. The device also offers efficient, effective, intensive sensorimotor therapy.

In a recent patient outcomes data report from Bionik, Using IoT Data to Quantify InMotion Therapy Gains on Upper Extremity Motor Impairments, patients using its robotic devices measured upwards of 15-20% improvement in their ability to move more smoothly, with intention, and in a controlled manner over a 14-day time-frame.

“The InMotion device will provide TGH’s clinicians with an invaluable technology that will offer each of their patients effective and efficient therapy sessions, allowing them to track upwards of 1,000 movements per session,” said Richard Russo, Jr., interim CEO and CFO of Bionik, in a prepared statement. “We are thrilled to be working with Tampa General Hospital as we continue to expand our presence with the Kindred network to reach more patients.”

The number of hospitals and rehabilitation centers in the United States that use an InMotion robotic device has increased three-fold since 2019. Through Bionik’s partnership with Kindred hospitals across the country, who use InMotion robotic devices within their inpatient rehabilitation facilities, more than 250 patients use the assistive robotic devices each month.

 

 

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish